Location History:
- Woodbridge, NJ (US) (2010)
- North Plainfield, NJ (US) (2012)
Company Filing History:
Years Active: 2010-2012
Title: Joann Bohn: Innovator in CETP Inhibitors
Introduction
Joann Bohn is a notable inventor based in North Plainfield, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of CETP inhibitors. With a total of two patents to her name, her work focuses on compounds that have the potential to improve cardiovascular health.
Latest Patents
Joann Bohn's latest patents involve CETP inhibitors, specifically compounds of Formula I. These compounds, including their pharmaceutically acceptable salts, are designed to raise HDL-cholesterol and reduce LDL-cholesterol. They are also useful for treating or preventing atherosclerosis. The compounds of Formula I feature A and A2, which can be an aromatic ring, a 5-6-membered heterocyclic ring, an aromatic ring fused to a heterocyclic ring, a phenyl ring fused to a heterocyclic ring, or a cycloalkyl ring.
Career Highlights
Joann Bohn is currently employed at Merck Sharp & Dohme Corporation, where she continues to innovate in the pharmaceutical industry. Her work has the potential to impact the treatment of cardiovascular diseases significantly.
Collaborations
Joann collaborates with talented coworkers, including Amjad Ali and Qiaolin Deng. Their combined expertise contributes to the advancement of their projects and the development of new therapeutic solutions.
Conclusion
Joann Bohn is a pioneering inventor whose work on CETP inhibitors is paving the way for advancements in cardiovascular health. Her contributions to the field are invaluable and demonstrate the importance of innovation in medicine.